The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Pharmaceuticals based on biologics and vaccines have seen significant growth over the past decade, with vaccines emerging as one of the fastest-growing market segments today. This rapid expansion has underscored the critical importance of cold chain management, as maintaining the quality and efficacy of these drug products is paramount. The success of biologics and vaccines heavily relies on stringent temperature control throughout the supply chain, ensuring that these sensitive products remain effective from production to administration.
The biopharma sector faces high growth expectations in Europe, making regional and country-specific cold chain expertise and storage capabilities essential. The integrity of the cold chain demands rigorous planning and oversight, as any break in the chain can result in losses of resources and time. The complexity of maintaining cold chain integrity across the European supply chain highlights the need for specialized knowledge and robust infrastructure to prevent disruptions and ensure that life-saving therapies reach patients in need.
Download our infographic to learn about top tips for maintaining the cold chain in European distribution.
